LFST250117P13000
- 0.00
- 0.000.00%
LifeStance Health Newsroom
Buy Rating for Lifestance Health Group Amid Potential Revenue Boost From Physician Fee Adjustments
Lifestance Health Group Secures New Credit Agreement
Express News | Lifestance Health Group Inc - Unit Enters Into Credit Agreement
Health-care Sector Faces Mixed Prospects in 2025, Morgan Stanley Says
Goldman Sachs Upgrades LifeStance Health(LFST.US) to Buy Rating, Announces Target Price $10
Strong Growth Potential and Strategic Advancements Position Lifestance Health Group for Future Success
10 Health Care Stocks With Whale Alerts In Today's Session
LifeStance Health Group (NASDAQ:LFST) Is Making Moderate Use Of Debt
Lifestance Health Group Insider Sold Shares Worth $565,500, According to a Recent SEC Filing
LifeStance Health Group Is Maintained at Underweight by Barclays
LifeStance Health Gr Analyst Ratings
Express News | Lifestance Health Group Inc : Barclays Raises Target Price to $7 From $6
Barclays Maintains LifeStance Health(LFST.US) With Sell Rating, Maintains Target Price $7
Barclays Sticks to Their Sell Rating for Lifestance Health Group (LFST)
Analyst Estimates: Here's What Brokers Think Of LifeStance Health Group, Inc. (NASDAQ:LFST) After Its Third-Quarter Report
LifeStance Health Group, Inc. (LFST) Q3 2024 Earnings Call Transcript Summary
LifeStance Health Group, Inc. (LFST) Q3 2024 Earnings Call Transcript
Morgan Stanley Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $10
LifeStance Health | 10-Q: Q3 2024 Earnings Report
LifeStance Health | 8-K: LifeStance Reports Third Quarter 2024 Results